FDA
approval
· 2025-12-22
FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
Summary
The FDA approved a supplemental application for a buprenorphine and naloxone product from Sun Pharmaceutical Industries, Inc., signifying approval of a generic …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE AND NALOXONE (BUPRENORPHINE AND NALOXONE)